BIOLARGO, INC. 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001437749-26-017391
- Form type
- 10-Q
- CIK
- 0000880242
- Primary document
- https://www.sec.gov/Archives/edgar/data/880242/000143774926017391/blgo20260331_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOLARGO, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Cost Of Revenue | $657,000 | - | - |
| Gross Profit | $458,000 | - | - |
| Operating Income | $-3.2M | - | - |
| Eps Basic | -0.01 | - | - |
| Cash And Equivalents | $4.1M | - | - |
| Total Assets | $8.6M | - | - |
| Total Liabilities | $8.8M | - | - |
| Shareholders Equity | $1.8M | - | - |
| Operating Cash Flow | $-2.9M | - | - |